AD-Related Dementias Focus
Promote career development of biomedical, behavioral, and social scientists conducting AD/ADRD health equity research.
2029 NOT-NS-21-047: Administrative Supplements to Promote Diversity for NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees PAR-22-022: NINDS Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) PAR-24-212: NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) PAR-24-213: NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed) 4.Z In Progress DN 2022 ADRD Summit: Health Equity in AD/ADRD, Milestone 3, Priority 2 Translational Tools, Infrastructure, and Capabilities
- Support at least two initiatives to promote career development and retention of AD/ADRD scientists from diverse backgrounds, including midcareer through senior levels.
- At least one initiative to expand AD/ADRD career development resources and opportunities, including by promoting equity in representation of diverse scholars at all levels.
Summary of Key Accomplishments
This milestone has just been initiated. Accomplishments are forthcoming.
The key accomplishments summary is current as of November 2022.